CROI 2025 Conference Coverage
CROI 2025 Conference Coverage
04/03/2025
Miranda Manier, BA
A new analysis found no difference in cardiovascular event rates between immediate and deferred antiretroviral therapy initiation among adults with HIV who had high CD4+ counts and low baseline...
04/03/2025
ACC.25 Conference Coverage
ACC.25 Conference Coverage
03/28/2025
Kate Young
New data suggests that continuing GLP-1 receptor agonists before surgery may improve outcomes for patients with type 2 diabetes.
03/28/2025
Research Summary
Research Summary
03/24/2025
Anthony Calabro, MA
Researchers set out to determine the prevalence of pickleball-related fractures examined in United States emergency departments from 2002 to 2022, as well the demographics associated with those fractures....
03/24/2025
Research Summary
Research Summary
03/13/2025
Anthony Calabro, MA
A retrospective cohort study suggested that colchicine prophylaxis at urate-lowering therapy initiation may lower cardiovascular event risk in patients with gout.
03/13/2025
Research Summary
Research Summary
03/03/2025
Miranda Manier, BA
A study assesses whether the dual sodium–glucose co-transporter (SGLT) 1/2 inhibitor sotagliflozin reduces ischemic events in diabetes and kidney disease.
03/03/2025
Research Summary
Research Summary
02/24/2025
Kate Young
A new study has found that older men with elevated serum phosphate levels face a significantly increased risk of fractures.
02/24/2025
Research Summary
Research Summary
02/15/2025
Kate Young
A new analysis found that acute anemia in patients who had a heart attack is associated with a higher risk of death or recurrent myocardial infarction at 30 days.
02/15/2025
Research Summary
Research Summary
02/04/2025
Anthony Calabro, MA
The US Preventive Services Task Force assessed the benefits and harms of osteoporosis screening in adults aged 40 years or older without a known diagnosis of osteoporosis or history of fragility fractures. ...
02/04/2025
FDA Alert
FDA Alert
01/28/2025
Anthony Calabro, MA
The FDA is seeking a cap on nicotine levels in cigarettes and certain tobacco products at minimally or nonaddictive levels. This initiative, if finalized, would be what the FDA calls a “significant step”...
01/28/2025
FDA Alert
FDA Alert
01/16/2025
Miranda Manier, BA
Acoramidis, an oral therapy, is now approved to reduce cardiovascular-related deaths and hospitalizations in adults with hereditary or wild-type ATTR-CM.
01/16/2025